Physician

Adil N Jaffer, M.D.

According to 2025 Medicare claims, Adil Jaffer, M.D. (NPI: 1699757781) practices family practice in the Youngstown-Warren, OH market, with the plurality of this provider's patient population coming from Mahoning, OH. This provider's primary affiliated billing organization is TRIAD HEALTH SERVICES, LLC (NPI: 1588925457; TIN: 454951682) and primary practice location at 44512-5980.

Jaffer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 74 traditional Medicare patients, billed 526 HCPCS/CPT codes, and received $23,506 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,350 prescription claims across 304 beneficiaries totaling $392,302 in drug costs, led by Ozempic (Semaglutide). 2023 DME data shows 36 claims. Open Payments data shows 21 records totaling $406. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $107,586 to $23,506. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $685,909 to $392,302. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,960 and ending at $3,658.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	250	2,175	$107,586
2016	261	2,482	$119,236
2017	230	1,881	$87,339
2018	190	1,085	$53,088
2019	198	837	$31,803
2020	122	675	$29,108
2021	97	718	$34,982
2022	97	590	$27,064
2023	90	482	$21,301
2024	74	526	$23,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	431	11,756	$685,909
2016	441	11,662	$735,944
2017	396	12,160	$831,033
2018	400	10,416	$750,917
2019	406	8,604	$627,206
2020	344	5,379	$442,000
2021	301	4,106	$382,760
2022	270	3,787	$374,809
2023	306	4,826	$405,491
2024	304	4,350	$392,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	108	$1,901
2016	38	161	$3,824
2017	14	126	$1,591
2018	32	163	$2,453
2019	37	150	$2,651
2020	N/R	65	$1,551
2021	N/R	13	$819
2022	N/R	39	$3,194
2023	N/R	36	$3,439
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	25	25	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	60	144	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	22	36	$64
96372	Injection of drug or substance under skin or into muscle	20	32	$10
36415	Insertion of needle into vein for collection of blood sample	38	83	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	76	2,352	$77,309
Eliquis	Apixaban	52	2,220	$42,783
Trulicity	Dulaglutide	29	1,204	$39,792
Januvia	Sitagliptin Phosphate	53	1,786	$33,734
Xarelto	Rivaroxaban	55	1,364	$26,703

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$406	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adil N. Jaffer, M.D.?

Tedicare shows public-source Medicare data for Adil N. Jaffer, M.D. (NPI 1699757781), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adil N. Jaffer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adil N. Jaffer, M.D.?

Adil N. Jaffer, M.D. is linked to TRIAD HEALTH SERVICES, LLC (billing NPI 1588925457) in the available physician profile data.

Does Adil N. Jaffer, M.D. have Open Payments data?

Adil N. Jaffer, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.